<If the EU approves pirfenidone, InterMune's stock price could rise easily into the mid-to-high $20s. (Some analysts forecast peak sales of pirfenidone in Europe alone reaching $1 billion.) >
That's Indian Rupees:::Rs 1 Billion!
"If the EU approves pirfenidone, InterMune's stock price could rise easily into the mid-to-high $20s..."
Now that's with ACTUAL EU APPROVAL, not
an advisory panel recommendation for approval...!
Remember the FDA's panel recommendation was also for approval just before FDA said
NYET NYET NYET!!!
Read the NEWS...EU countries FALLING
like blackbirds on New Year's!!!
"He bought the stock that MORNING and SOLD as soon as Market opened for a QUICK $15 Million Profit!!!"
He didn't make anything close to $15m profit. These were options that he exercised based on a predetermined share price. Geez. Enough already.